Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

160 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Eculizumab is a safe and effective treatment in pediatric patients with atypical hemolytic uremic syndrome.
Greenbaum LA, Fila M, Ardissino G, Al-Akash SI, Evans J, Henning P, Lieberman KV, Maringhini S, Pape L, Rees L, van de Kar NC, Vande Walle J, Ogawa M, Bedrosian CL, Licht C. Greenbaum LA, et al. Among authors: ardissino g. Kidney Int. 2016 Mar;89(3):701-11. doi: 10.1016/j.kint.2015.11.026. Epub 2016 Jan 28. Kidney Int. 2016. PMID: 26880462 Free article. Clinical Trial.
Risk factors for poor renal prognosis in children with hemolytic uremic syndrome.
Gianviti A, Tozzi AE, De Petris L, Caprioli A, Ravà L, Edefonti A, Ardissino G, Montini G, Zacchello G, Ferretti A, Pecoraro C, De Palo T, Caringella A, Gaido M, Coppo R, Perfumo F, Miglietti N, Ratsche I, Penza R, Capasso G, Maringhini S, Li Volti S, Setzu C, Pennesi M, Bettinelli A, Peratoner L, Pela I, Salvaggio E, Lama G, Maffei S, Rizzoni G. Gianviti A, et al. Among authors: ardissino g. Pediatr Nephrol. 2003 Dec;18(12):1229-35. doi: 10.1007/s00467-003-1262-6. Epub 2003 Oct 31. Pediatr Nephrol. 2003. PMID: 14593522
Puberty is associated with increased deterioration of renal function in patients with CKD: data from the ItalKid Project.
Ardissino G, Testa S, Daccò V, Paglialonga F, Viganò S, Felice-Civitillo C, Battaglino F, Bettinelli A, Bordugo A, Cecchetti V, De Pascale S, La Manna A, Li Volti S, Maringhini S, Montini G, Pennesi M, Peratoner L. Ardissino G, et al. Arch Dis Child. 2012 Oct;97(10):885-8. doi: 10.1136/archdischild-2011-300685. Epub 2012 Jul 25. Arch Dis Child. 2012. PMID: 22833407
Eculizumab for atypical hemolytic uremic syndrome recurrence in renal transplantation.
Zuber J, Le Quintrec M, Krid S, Bertoye C, Gueutin V, Lahoche A, Heyne N, Ardissino G, Chatelet V, Noël LH, Hourmant M, Niaudet P, Frémeaux-Bacchi V, Rondeau E, Legendre C, Loirat C; French Study Group for Atypical HUS. Zuber J, et al. Among authors: ardissino g. Am J Transplant. 2012 Dec;12(12):3337-54. doi: 10.1111/j.1600-6143.2012.04252.x. Epub 2012 Sep 7. Am J Transplant. 2012. PMID: 22958221 Free article.
Skin involvement in atypical hemolytic uremic syndrome.
Ardissino G, Tel F, Testa S, Marzano AV, Lazzari R, Salardi S, Edefonti A. Ardissino G, et al. Am J Kidney Dis. 2014 Apr;63(4):652-5. doi: 10.1053/j.ajkd.2013.09.020. Epub 2013 Nov 27. Am J Kidney Dis. 2014. PMID: 24290245
Time to change the definition of hemolytic uremic syndrome.
Ardissino G, Possenti I, Tel F, Testa S, Paglialonga F. Ardissino G, et al. Eur J Intern Med. 2014 Feb;25(2):e29. doi: 10.1016/j.ejim.2013.12.002. Epub 2013 Dec 21. Eur J Intern Med. 2014. PMID: 24360866 No abstract available.
160 results